NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/02/2026
Voltar para busca
Dado oficial do USPTO
BEHRING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
71
Atualização mais recente
06/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
12/02/2004
Data de registro
08/08/2006
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/02/2026
Última transação
06/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
US
Examinador
RIRIE, VERNA BETH
Localização atual
Historical data usage
Titulares e representantes
Titulares
CSL Behring L.L.C.
Hoechst GmbH
H. A. (pessoa física)
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
[ Diagnostic preparations and reagents for medical use; vaccines; ] pharmaceutical preparations for the treatment of hemophilia, blood coagulation disorders and immune system disorders; [ pharmaceutical preparations for the inhibition of blood clots; ] pharmaceutical preparations for promoting wound healing; and pharmaceutical preparations, namely, blood plasma expanders
Classe 10
[ Diagnostic products for use in clinical laboratories, namely, diagnostic systems used to generate diagnostic test results and to measure and test blood and other biological samples, comprised of analyzers, computer hardware, software and documentation, all sold as a unit for coagulation, protein, infectious disease, immunochemistry, chemistry, nucleic diagnostic testing, cancer, fertility, diabetes, cardiac function, thyroid testing, testing for health related conditions, and microbiology testing; medical and clinical diagnostic analyzers for use in specimen testing, drug testing, specimen validity analysis, and for serum toxicology assays; Medical apparatus for clinical and medical diagnostic use, namely, sample tube conveyors for use in the automation of biological sample processing and analysis of information related thereto; and empty container cartridges for clinical laboratory medical use to contain diagnostic reagents ]
Publicações
Histórico de despachos e eventos da marca no USPTO.
71 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
05/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/01/2026
ES71
TEAS SECTION 71 RECEIVED
23/09/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/08/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
29/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/11/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/12/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
23/05/2017
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/04/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2017
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
17/08/2016
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
17/08/2016
PLGL
ASSIGNED TO PARALEGAL
17/08/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/08/2016
71AG
REGISTERED-SEC.71 ACCEPTED
06/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/08/2016
ES71
TEAS SECTION 71 RECEIVED
29/06/2016
E15R
TEAS SECTION 15 RECEIVED
29/06/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/02/2016
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
01/05/2014
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/04/2014
RNWL
INTERNATIONAL REGISTRATION RENEWED
27/02/2014
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/05/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/02/2013
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
11/09/2012
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
11/09/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/09/2012
71AF
REGISTERED-SEC.71 FILED
07/08/2012
ES71
TEAS SECTION 71 RECEIVED
07/08/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/04/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/04/2007
FIMP
FINAL DISPOSITION PROCESSED
04/04/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/03/2007
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/11/2006
CHLD
CHANGE OF OWNER RECEIVED FROM IB
15/09/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2006
PUBO
PUBLISHED FOR OPPOSITION
16/05/2006
NPUB
NOTICE OF PUBLICATION
26/04/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/03/2006
ALIE
ASSIGNED TO LIE
24/03/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/03/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/02/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/02/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/02/2006
CPRA
PRIORITY ACTION MAILED
20/12/2005
CPRA
PRIORITY ACTION WRITTEN
19/12/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
28/11/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2005
PAPER RECEIVED
14/11/2005
CNRT
NON-FINAL ACTION MAILED
02/06/2005
CNRT
NON-FINAL ACTION WRITTEN
02/06/2005
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
25/05/2005
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
12/05/2005
CNFR
FINAL REFUSAL MAILED
11/04/2005
CNFR
FINAL REFUSAL WRITTEN
08/04/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/03/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2005
PAPER RECEIVED
11/02/2005
RFNT
REFUSAL PROCESSED BY IB
08/10/2004
CNRT
NON-FINAL ACTION MAILED
10/09/2004
CNRT
NON-FINAL ACTION WRITTEN
06/09/2004
DOCK
ASSIGNED TO EXAMINER
02/09/2004
NWAP
NEW APPLICATION ENTERED
19/07/2004
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/07/2004
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BEHRING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.